Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine.

[1]  Mary Goldman,et al.  The UCSC Genome Browser database: extensions and updates 2013 , 2012, Nucleic Acids Res..

[2]  E. Burchard,et al.  Genetic ancestry and its association with asthma exacerbations among African American subjects with asthma. , 2012, The Journal of allergy and clinical immunology.

[3]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[4]  B. Chipps.  Genomewide Association Between GLCCI1 and Response to Glucocorticoid Therapy in Asthma , 2012, Pediatrics.

[5]  A. Dahlin,et al.  Integrative systems biology approaches in asthma pharmacogenomics. , 2012, Pharmacogenomics.

[6]  Christopher R. Gignoux,et al.  Genome-wide ancestry association testing identifies a common European variant on 6q14.1 as a risk factor for asthma in African American subjects. , 2012, The Journal of allergy and clinical immunology.

[7]  Yusuke Nakamura,et al.  Genome-Wide Association Analysis in Asthma Subjects Identifies SPATS2L as a Novel Bronchodilator Response Gene , 2012, PLoS genetics.

[8]  Ryan D. Hernandez,et al.  Case-control admixture mapping in Latino populations enriches for known asthma-associated genes. , 2012, The Journal of allergy and clinical immunology.

[9]  R. Wu,et al.  Genome-wide Association Identifies the T Gene as a Novel Asthma Pharmacogenetic Locus at a Glance Commentary , 2022 .

[10]  K. Roeder,et al.  African ancestry and lung function in Puerto Rican children. , 2012, The Journal of allergy and clinical immunology.

[11]  A. Clark,et al.  Recent Explosive Human Population Growth Has Resulted in an Excess of Rare Genetic Variants , 2012, Science.

[12]  E. Bleecker,et al.  Effect of β2-adrenergic receptor gene (ADRB2) 3′ untranslated region polymorphisms on inhaled corticosteroid/long-acting β2-adrenergic agonist response , 2012, Respiratory Research.

[13]  Mary Goldman,et al.  The UCSC Genome Browser database: extensions and updates 2011 , 2011, Nucleic Acids Res..

[14]  E. R. Sutherland,et al.  Impact of race on asthma treatment failures in the asthma clinical research network. , 2011, American journal of respiratory and critical care medicine.

[15]  F. Gilliland,et al.  New Mexican Hispanic smokers have lower odds of chronic obstructive pulmonary disease and less decline in lung function than non-Hispanic whites. , 2011, American journal of respiratory and critical care medicine.

[16]  B. Nordestgaard,et al.  &bgr;2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies , 2011, European Respiratory Journal.

[17]  Xihong Lin,et al.  Rare-variant association testing for sequencing data with the sequence kernel association test. , 2011, American journal of human genetics.

[18]  Mark S Levenson,et al.  Assessing the safety of adding LABAs to inhaled corticosteroids for treating asthma. , 2011, The New England journal of medicine.

[19]  E. Bleecker,et al.  Regulatory haplotypes in ARG1 are associated with altered bronchodilator response. , 2011, American journal of respiratory and critical care medicine.

[20]  D. Reich,et al.  Ancestry informative marker panels for African Americans based on subsets of commercially available SNP arrays , 2011, Genetic epidemiology.

[21]  Sharon R Grossman,et al.  Integrating common and rare genetic variation in diverse human populations , 2010, Nature.

[22]  Alex P. Reiner,et al.  Genetic ancestry in lung-function predictions. , 2010, The New England journal of medicine.

[23]  J. Stamler,et al.  GSNO reductase and β2-adrenergic receptor gene–gene interaction: bronchodilator responsiveness to albuterol , 2010, Pharmacogenetics and genomics.

[24]  M. King,et al.  Genetic Heterogeneity in Human Disease , 2010, Cell.

[25]  S. Tsuji.  Genetics of neurodegenerative diseases: insights from high-throughput resequencing , 2010, Human molecular genetics.

[26]  E. Bleecker,et al.  Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate. , 2010, American journal of respiratory and critical care medicine.

[27]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[28]  Daniel J Jackson,et al.  Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. , 2010, The New England journal of medicine.

[29]  D. Postma,et al.  Arginase 1 and arginase 2 variations associate with asthma, asthma severity and β2 agonist and steroid response , 2010, Pharmacogenetics and genomics.

[30]  D. Curran‐Everett,et al.  Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. , 2010, American journal of respiratory and critical care medicine.

[31]  E. Zeggini,et al.  An Evaluation of Statistical Approaches to Rare Variant Analysis in Genetic Association Studies , 2009, Genetic epidemiology.

[32]  E. R. Sutherland,et al.  Effect of β2-adrenergic receptor polymorphism on response to longacting β2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial , 2009, The Lancet.

[33]  Blanca E Himes,et al.  Predicting response to short-acting bronchodilator medication using Bayesian networks. , 2009, Pharmacogenomics.

[34]  David H. Alexander,et al.  Fast model-based estimation of ancestry in unrelated individuals. , 2009, Genome research.

[35]  E. Bleecker,et al.  The glucocorticoid receptor heterocomplex gene STIP1 is associated with improved lung function in asthmatic subjects treated with inhaled corticosteroids. , 2009, The Journal of allergy and clinical immunology.

[36]  J. Sylvia,et al.  5-Lipoxygenase pharmacogenetics in asthma: overlap with Cys-leukotriene receptor antagonist loci , 2009, Pharmacogenetics and genomics.

[37]  F. Radner,et al.  Long-acting β-agonists: a review of formoterol safety data from asthma clinical trials , 2009, European Respiratory Journal.

[38]  E. Bleecker,et al.  ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts. , 2008, American journal of respiratory and critical care medicine.

[39]  S. Peters,et al.  Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients. , 2008, Allergy and asthma proceedings.

[40]  A. Armentia,et al.  ALOX5 promoter genotype and response to montelukast in moderate persistent asthma. , 2008, Respiratory medicine.

[41]  J. Spertus,et al.  A GRK5 polymorphism that inhibits β-adrenergic receptor signaling is protective in heart failure , 2008, Nature Medicine.

[42]  R. Mei,et al.  Genome-wide screen for asthma in Puerto Ricans: evidence for association with 5q23 region , 2008, Human Genetics.

[43]  D. Postma,et al.  Effect of ADRB2 polymorphisms on response to longacting β2-agonist therapy: a pharmacogenetic analysis of two randomised studies , 2007, The Lancet.

[44]  Xiaofeng Zhu,et al.  Admixture mapping and the role of population structure for localizing disease genes. , 2008, Advances in genetics.

[45]  E. Bleecker,et al.  Pharmacogenetics of the β2-Adrenergic Receptor Gene , 2007 .

[46]  Zhaohui S. Qin,et al.  A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.

[47]  J. Mountain,et al.  Race and ethnicity in genetic research , 2007, American journal of medical genetics. Part A.

[48]  Tom Walsh,et al.  Ten genes for inherited breast cancer. , 2007, Cancer cell.

[49]  D. Curran‐Everett,et al.  Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. , 2007, The Journal of allergy and clinical immunology.

[50]  E. Burchard,et al.  Ethnic-Specific Differences in Bronchodilator Responsiveness Among African Americans, Puerto Ricans, and Mexicans with Asthma , 2007, The Journal of asthma : official journal of the Association for the Care of Asthma.

[51]  E. Bleecker,et al.  Pharmacogenetics of the beta 2-adrenergic receptor gene. , 2007, Immunology and allergy clinics of North America.

[52]  W. Busse,et al.  Severe asthma: lessons from the Severe Asthma Research Program. , 2007, The Journal of allergy and clinical immunology.

[53]  N. Risch,et al.  Ancestry-environment interactions and asthma risk among Puerto Ricans. , 2006, American journal of respiratory and critical care medicine.

[54]  Deborah A Meyers,et al.  Sequence, haplotype, and association analysis of ADRbeta2 in a multiethnic asthma case-control study. , 2006, American journal of respiratory and critical care medicine.

[55]  L. Edwards,et al.  Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma. , 2006, The Journal of allergy and clinical immunology.

[56]  L. Lazzeroni,et al.  A polymorphism within a conserved β1-adrenergic receptor motif alters cardiac function and β-blocker response in human heart failure , 2006 .

[57]  E. Salpeter,et al.  Meta-Analysis: Effect of Long-Acting -Agonists on Severe Asthma Exacerbations and Asthma-Related Deaths , 2006, Annals of Internal Medicine.

[58]  D. Mannino,et al.  Asthma prevalence among US adults, 1998-2000: role of Puerto Rican ethnicity and behavioral and geographic factors. , 2006, American journal of public health.

[59]  Kathleen Barnes,et al.  Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. , 2006, American journal of respiratory and critical care medicine.

[60]  Jonathan C. Cohen,et al.  Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[61]  P. Dorinsky,et al.  The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. , 2006, Chest.

[62]  L. Lazzeroni,et al.  A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[63]  M. Ní Chróinín,et al.  Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. , 2005, The Cochrane database of systematic reviews.

[64]  Sang-Heon Cho,et al.  Association between bronchodilating response to short‐acting β‐agonist and non‐synonymous single‐nucleotide polymorphisms of β2‐adrenoceptor gene , 2005 .

[65]  P. Sly,et al.  Lyn-Deficient Mice Develop Severe, Persistent Asthma: Lyn Is a Critical Negative Regulator of Th2 Immunity 1 , 2005, The Journal of Immunology.

[66]  N. Risch,et al.  Genetic admixture and asthma‐related phenotypes in Mexican American and Puerto Rican asthmatics , 2005, Genetic epidemiology.

[67]  S. Weiss,et al.  Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between beta-agonist and corticosteroid pathways. , 2005, Human molecular genetics.

[68]  E. Silverman,et al.  Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. , 2005, American journal of respiratory and critical care medicine.

[69]  Xiaofeng Zhu,et al.  Genetic Structure, Self-identified Race/ethnicity, and Confounding in Case-control Association Studies , 2022 .

[70]  K. Min,et al.  Association between bronchodilating response to short-acting beta-agonist and non-synonymous single-nucleotide polymorphisms of beta-adrenoceptor gene. , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[71]  B. Butland,et al.  Bronchodilator treatment and deaths from asthma: case-control study , 2004, BMJ : British Medical Journal.

[72]  Giovanni Montana,et al.  Statistical tests for admixture mapping with case-control and cases-only data. , 2004, American journal of human genetics.

[73]  E. Israel,et al.  Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial , 2004, The Lancet.

[74]  Jonathan C. Cohen,et al.  Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol , 2004, Science.

[75]  Scott M. Williams,et al.  A high-density admixture map for disease gene discovery in african americans. , 2004, American journal of human genetics.

[76]  M. Daly,et al.  Methods for high-density admixture mapping of disease genes. , 2004, American journal of human genetics.

[77]  I. Hall,et al.  The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol. , 2003, British journal of clinical pharmacology.

[78]  Pui-Yan Kwok,et al.  Sequence variations in the public human genome data reflect a bottlenecked population history , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[79]  S. Green,et al.  The Ile164 β2-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to Gs , 2001 .

[80]  M. Domanski,et al.  A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. , 2001, The New England journal of medicine.

[81]  T. R. I. Nvestigators.  A TRIAL OF THE BETA-BLOCKER BUCINDOLOL IN PATIENTS WITH ADVANCED CHRONIC HEART FAILURE , 2001 .

[82]  S. Green,et al.  The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s). , 2001, European journal of pharmacology.

[83]  Christopher J. Lee,et al.  Genome-wide analysis of single-nucleotide polymorphisms in human expressed sequences , 2000, Nature Genetics.

[84]  Eric S. Lander,et al.  An SNP map of the human genome generated by reduced representation shotgun sequencing , 2000, Nature.

[85]  R S Judson,et al.  Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[86]  P Bork,et al.  SNP frequencies in human genes an excess of rare alleles and differing modes of selection. , 2000, Trends in genetics : TIG.

[87]  Jeff Shaw,et al.  $9 Billion for What? , 2000 .

[88]  E. Silverman,et al.  The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. , 2000, American journal of respiratory and critical care medicine.

[89]  D. Mannino,et al.  Asthma mortality in U.S. Hispanics of Mexican, Puerto Rican, and Cuban heritage, 1990-1995. , 2000, American journal of respiratory and critical care medicine.

[90]  H. Harpending,et al.  Genetic perspectives on human origins and differentiation. , 2000, Annual review of genomics and human genetics.

[91]  E. Silverman,et al.  Heterogeneity of therapeutic responses in asthma. , 2000, British medical bulletin.

[92]  D. Thomason,et al.  Impact of genetic polymorphisms of the β2‐adrenergic receptor on albuterol bronchodilator pharmacodynamics , 1999, Clinical pharmacology and therapeutics.

[93]  B. Gersh,et al.  Racial differences in the outcome of left ventricular dysfunction. , 1999, The New England journal of medicine.

[94]  E. Lander,et al.  Characterization of single-nucleotide polymorphisms in coding regions of human genes , 1999 .

[95]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.

[96]  B K Tang,et al.  Hypothesis: comparisons of inter- and intra-individual variations can substitute for twin studies in drug research. , 1998, Pharmacogenetics.

[97]  S. Sherry,et al.  Alu evolution in human populations: using the coalescent to estimate effective population size. , 1997, Genetics.

[98]  I. Hall,et al.  Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. , 1995, American journal of respiratory cell and molecular biology.

[99]  S. Green,et al.  Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. , 1994, Biochemistry.

[100]  S. Green,et al.  A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. , 1993, The Journal of biological chemistry.

[101]  W. Castle,et al.  Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. , 1993, BMJ.

[102]  P. Gergen,et al.  Reported asthma among Puerto Rican, Mexican-American, and Cuban children, 1982 through 1984. , 1993, American journal of public health.

[103]  E. Vesell,et al.  Pharmacogenetic perspectives gained from twin and family studies. , 1989, Pharmacology & therapeutics.